{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:24:24Z","timestamp":1747207464646,"version":"3.40.5"},"reference-count":11,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["IDDT"],"published-print":{"date-parts":[[2021,4,14]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Cotrimoxazole is the main antibiotic used in HIV-infected patients for\nthe prophylaxis of opportunistic infections. This antibiotic is prescribed in patients receiving\nantiretroviral agents (ART) such as Atazanavir (ATV), a protease inhibitor used with other ART\nclasses.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>The objective of this study was to compare HIV treatment failure (HIVTF) in HIV-infected patients\ntreated concomitantly with ATV and cotrimoxazole to those of patients treated only with\nATV.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Materials and Methods:<\/jats:title>\n<jats:p>This is a comparative analysis of the safety data of HIVTF available with\nATV in the WHO International Pharmacovigilance database \"VigiBase\u00ae\". We used the SMQ\n(Standardized MedDRA Querie) to identify all the terms corresponding to HIVTF. We presented\nresults as a percentage or an adjusted Reporting Odds Ratio (aROR) with a 95% confidence interval\n(95% CI).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> A total of 116 cases of HIVTF (2.2%) were reported with ATV among the 5196 individual\ncase safety reports (ICSR) included in the analysis. The proportion of HIV-infected patients\nwho presented ATV treatment failure (ATVTF) was lower (2.6%, 3\/116) when cotrimoxazole was\nconcomitant (aROR was 0.5 with a 95%CI from 0.2 to 1.7). Only 10 of 273 ICSRs (3.7%) were\nreported from Africa concerning the use of cotrimoxazole prophylaxis concomitantly with ATV.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>This study did not show a higher occurrence of ATVTF when cotrimoxazole was\nconcomitant. These results reinforce the place of concomitant use of ATV with cotrimoxazole in\nthe management of HIV treatment.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871526520666191220112416","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T13:07:39Z","timestamp":1576847259000},"page":"55-59","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cotrimoxazole Prophylaxis is Not Associated with a Higher Occurrence of Atazanavir Treatment Failure: Analysis of Worldwide Pharmacovigilance Data"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5658-9382","authenticated-orcid":true,"given":"Joe Miantezila","family":"Basilua","sequence":"first","affiliation":[{"name":"Microbial Ecology Laboratory (MIEL), CNAM, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Pochart","sequence":"additional","affiliation":[{"name":"Microbial Ecology Laboratory (MIEL), CNAM, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"journal-title":"Global action plan on HIV drug resistance 2017\u20132021\nWHO","year":"2018","key":"ref=1","unstructured":"Global action plan on HIV drug resistance 2017\u20132021\nWHO WHOAvailable from: \n                     ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.who.int\/hiv\/pub\/drugresistance\/hivdr-action-plan-2017-2021\/en\/\">http:\/\/www.who.int\/hiv\/pub\/drugresistance\/hivdr-action-plan-2017-2021\/en\/2018"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40264-015-0387-4","volume":"39","author":"Ampadu H.H.","year":"2016","unstructured":"Ampadu H.H.; Hoekman J.; de Bruin M.L.; Pal S.N.; Olsson S.; Sartori D.; Leufkens H.G.; Dodoo A.N.; Adverse drug reaction reporting in africa and a comparison of individual case safety report characteristics between africa and the rest of the world: analyses of spontaneous reports in VigiBase\u00ae. Drug Saf 2016,39(4),335-345","journal-title":"Drug Saf"},{"key":"ref=3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089943","volume":"9","author":"Dossou-Yovo F.","year":"2014","unstructured":"Dossou-Yovo F.; Mamadou G.; Soudy I.D.; Limas-Nzouzi N.; Miantezila J.; Desjeux J-F.; Eto B.; Metronidazole or Cotrimoxazole therapy is associated with a decrease in intestinal bioavailability of common antiretroviral drugs. PLoS One 2014,9(2)","journal-title":"PLoS One"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/infdis\/jix409","volume":"216","author":"Wallis C.L.","year":"2017","unstructured":"Wallis C.L.; Godfrey C.; Fitzgibbon J.E.; Mellors J.W.; Key\nfactors influencing the emergence of human immunodeficiency virus drug resistance in low- and middle-income countries. J Infect\nDis 2017,216(suppl_9),851-856","journal-title":"J Infect\nDis"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1586\/14787210.2015.1068117","volume":"13","author":"Jenabian M.A.","year":"2015","unstructured":"Jenabian M.A.; Costiniuk C.T.; Mboumba Bouassa R.S.; Chapdeleine Mekue Mouafo L.; Brogan T.V.; B\u00e9lec L.; Tackling virological failure in HIV-infected children living in Africa. Expert Rev Anti Infect Ther 2015,13(10),1213-1223","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref=6","first-page":"5551","volume":"69","year":"2004","unstructured":"HHS. International Conference on\nHarmonisation; Guidance on Addendum to E2C Clinical Safety\nData Management: Periodic Safety Update Reports for Marketed\nDrugs; availability. Notice. Fed Regist Food and Drug Administration2004,69(24),5551-5552","journal-title":"Fed Regist"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"898","DOI":"10.2174\/1389200220666191023105609","volume":"20","author":"Joe M.B.","year":"2019","unstructured":"Joe M.B.; Olivier S.; Ir\u00e8ne M.; Flore D-Y.; Aline B.; Lucie C.; Gaston T.L.; Bruno E.; Gilles P.; Philippe P.; Higher Atazanavir plasma exposure in Rats is associated with Gut Microbiota Changes induced by Cotrimoxazole. Curr Drug Metab 2019,20(11),898-906","journal-title":"Curr Drug Metab"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2174\/1574884714666190405160612","volume":"14","author":"Joe M.B.","year":"2019","unstructured":"Joe M.B.; Rolandc L.; Laurentg C.; Patrick L.M.; Sawoo O.; Gastonf T.L.; Brunoe E.; Gilles P.; Philippe P.; Concomitant use of Cotrimoxazole and Atazanavir in HIV-infected patients: A Therapeutic Drug Monitoring and Pharmacovigilance based dual approach. Curr Clin Pharmacol 2019,14(3),214-223","journal-title":"Curr Clin Pharmacol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/009286150804200501","volume":"42","author":"Lindquist M.","year":"2008","unstructured":"Lindquist M.; VigiBase, the WHO Global ICSR Database System: Basic Facts. Drug Inf J 2008,42(5),409-419","journal-title":"Drug Inf J"},{"journal-title":"Overview of HIV infection in South Africa Disponible\nsur","year":"2018","key":"ref=10","unstructured":"Overview of HIV infection in South Africa Disponible\nsur UNAIDSAvailable from:  ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.unaids.org\/en\/regionscoun-tries\/countries\/southafrica\">http:\/\/www.unaids.org\/en\/regionscoun-tries\/countries\/southafrica2018"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S2055-6640(20)30347-2","volume":"4","author":"Waal D.R.","year":"2018","unstructured":"Waal D.R.; Lessells R.; Hauser A.; Kouyos R.; Davies M-A.; Egger M.; Wandeler G.; HIV drug resistance in sub-Saharan Africa: Public health questions and the potential role of real-world data and mathematical modelling. J Virus Erad 2018,4(Suppl. 2),55-58","journal-title":"J Virus Erad"}],"container-title":["Infectious Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/177658","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/177658\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/177658","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T14:32:36Z","timestamp":1634481156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/177658\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,14]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,4,14]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871526520666191220112416","relation":{},"ISSN":["1871-5265"],"issn-type":[{"type":"print","value":"1871-5265"}],"subject":[],"published":{"date-parts":[[2021,4,14]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-09-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}